Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
90.76
+0.26 (0.29%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Merit Medical Systems Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Merit Medical Systems stock has a consensus rating of "Buy" and an average price target of $100.27. The average 1-year stock price forecast is 10.48% higher than the current stock price, while the lowest is $83 (-8.55%) and the highest is $114 (+25.61%).

Price Target: $100.27 (+10.48%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$83$100.27$100$114
Change-8.55%+10.48%+10.18%+25.61%

Analyst Ratings

The average analyst rating for Merit Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy444444
Buy555555
Hold222222
Sell000000
Strong Sell000000
Total111111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$94
BuyMaintains$94+3.57%Aug 12, 2026
BTIG
BTIG
Buy
Reiterates
$105
BuyReiterates$105+15.69%Aug 11, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$95
BuyMaintains$95+4.67%Aug 5, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
n/a
HoldMaintainsn/an/aJul 31, 2026
Barrington
Barrington
Buy
Maintains
$107$114
BuyMaintains$107$114+25.61%Jul 31, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.64B
from 1.52B
Increased by 7.94%
Revenue Next Year
1.74B
from 1.64B
Increased by 6.09%
EPS This Year
4.30
from 3.83
Increased by 12.33%
EPS Next Year
4.61
from 4.30
Increased by 7.19%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.07B1.15B1.26B1.36B1.52B1.64B
Revenue Growth
11.50%7.09%9.24%7.89%11.75%7.94%
Gross Profit
485.33M519.10M583.87M643.33M738.27M890.95M
Gross Margin
45.16%45.10%46.44%47.43%48.70%54.45%
Operating Income
84.40M108.26M135.07M168.04M193.90M347.99M
Net Income
48.45M74.52M94.41M120.36M128.49M169.02M
EPS
----3.834.30
EPS Growth
----10.69%12.33%
Forward PE
27.7025.9724.0427.1322.5121.10
Free Cash Flow
142.07M51.35M106.20M184.91M179.71M237.41M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.6B
Avg1.6B
Low1.6B

Revenue Growth

Revenue Growth202620272028
High
8.1%
Avg
7.9%
Low
7.7%

EPS Forecast

EPS202620272028
High4.32
Avg4.30
Low4.28

EPS Growth

EPS Growth202620272028
High
12.8%
Avg
12.3%
Low
11.7%